On Sunday, AstraZeneca Plc AZN reported positive late-stage data for investigational therapy efzimfotase alfa in children ...
As the number of people taking GLP-1 medications for diabetes or weight loss increases, more dietitians—including those who don’t specifically work in weight or diabetes management—will see these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results